MedTrace Logo

Impact of Tamsulosin on Voiding Patterns Following Early Catheter Removal After Robot-assisted Laparoscopic Radical Prostatectomy

NCT01209988 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2010-09-28

No results posted yet for this study

Summary

To date, there is a lack of consensus concerning the optimal timing for removal of the urethral catheter, its related complications, the effectiveness in prophylactic drug use to reduce complication, and the patient reported outcomes (quality of life) after robot-assisted laparoscopic prostatectomy (RALP). The purpose of this study is to determine the impact of tamsulosin on voiding patterns following early urethral catheter removal after RALP for prostate cancer.

Conditions

  • Prostatic Neoplasms, Prostatectomy

Interventions

DRUG

tamsulosin 0.4mg

perioperative tamsulosin 0.4mg daily for three weeks

OTHER

No medication

No medication

Sponsors & Collaborators

  • Astellas Pharma Inc

    collaborator INDUSTRY

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Choung-Soo Kim, M.D. · Department of Urology, Asan Medical Center, Seoul, Korea

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01209988 on ClinicalTrials.gov